JANE BUCHAN - 11 Aug 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Issuer symbol
IMMX
Transactions as of
11 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 17:15:46 UTC
Previous filing
30 Jun 2023
Next filing
11 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +20,000 $0.000000 20,000 11 Aug 2023 Common Stock 20,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 12 months from the date of grant.